European Biotechnology Spring 2018
Bioprocessing & cGMP
SPECIAL
SPECIAL Special: Bioprocessing & cGMP Get on Board! › Publication date: 9 March, 2018
Hot topics in bioprocessing & GMP compliance Whether companies have own resources for biologics production or whether contract research organisations do the job: novel molecule formats, cell & gene therapies, more productive cell lines and continous manufacturing challenge their capabilities to innovate and differentiate from the rest of the pack. In the EU, the finalised ATMP guidelines, the new Annex 1 on Sterile Manufacturing, and the BREXIT also challenge the capabilities of producers to remain cGMP-compliant, particularly with emerging medicine formats such as CAR-T cell therapies. As novel formats for biologics and biosimilars emerge, diversification through special know-how is key to market success as well as it is in adapting to regulatory-driven innovations such as QbD or continous manufacturing.
Present your expertise CMOs & biologics producers, plant engineering experts, equipment and software specialists as well as QBD experts will have the opportunity to present their latest products, processes, and equipment in this special. EuropBiotech Magazine goes out to decision makers throughout the entire European Life Sciences sector. Take advantage of to the journal’s highly relevant readership and grab this opportunity to target your audience!
Topics to be covered New products/processes, USP, DSP, single use/stainless steel equipment, media/cell line development, glycooptimisation, antibody conjugates, fill & finish, QbD, process development automation, DoE, GMP for cell/gene therapy, serialisation, cGMP risk analysis and documentation, digital tools, batch vs continous bioprocessing
Editorial Deadline 19-02-2018 Editorial Contact: Thomas Gabrielczyk Tel: +49-30-264921-50 Fax: +49-30-264921-11 t.gabrielczyk@biocom.de
Booking Deadline 19-02-2018
Publication Date 09-03-2018
Marketing Contact: Marketing Contact: Oliver Schnell Andreas Macht Tel: +49-30-264921-45 Tel: +49-30-264921-54 Fax: +49-30-264921-11 Fax: +49-30-264921-11 o.schnell@biocom.de a.macht@biocom.de
BIOCOM AG | Luetzowstr. 33–36 | D-10785 Berlin | www.biocom.de
Special: Bioprocessing & cGMP
Meet your audience!
European Biotechnology is published in co-operation with the following organisations: European Biotechnology NET WORK
Europe: european-biotechnology.net
Europe: medtecheurope.org
Europe: europabio.org
Europe: diahome.org
Switzerland: swissbiotech.org
Spain: asebio.com
Europe: medicinesforeurope.com
Ireland: ibec.ie/ibia
Denmark: danskbiotek.dk
The Netherlands: hollandbio.nl
Germany: biodeutschland.org
Portugal: www.p-bio.org
Austria: lifescienceaustria.at
France: france-biotech.org
Council of European BioRegions
CMYK
Italy: assobiotec.it
Sweden: swedenbio.com
Hungary: hungarianbiotech.org
Europe: cebr.net
Europe: ebe-biopharma.org
Norway: biotekforum.no
Finland: finbio.net
Belgium: bio.be
Blue: 100/15/0/35 Orange: 0/75/90/0
European Biotechnology covers the biotechnology sector of the current 28 EU member states, Norway and Switzerland. If you would like to subscribe, please refer to european-biotechnology.com
EBE
White Paper on Personalised Medicine